PETER KIES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER KIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER KIES. PETER KIES is CFO in INOVIO PHARMACEUTICALS, INC. ($GEB).
Latest Insider Trading Transactions of PETER KIES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 8.52 | 10,000 | 85,200 | 160,788 | 170.8 K to 160.8 K (-5.86 %) |
| Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 59,737 | 0 | 119,474 | |
| Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 10.57 | 31,410 | 332,004 | 170,788 | 202.2 K to 170.8 K (-15.53 %) |
| Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 59,737 | 0 | 202,198 | 142.5 K to 202.2 K (+41.93 %) |
| Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 21,467 | 0 | 21,466 | |
| Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 27,566 | 0 | 0 | |
| Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 8.91 | 11,288 | 100,576 | 142,461 | 153.7 K to 142.5 K (-7.34 %) |
| Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 21,467 | 0 | 153,749 | 132.3 K to 153.7 K (+16.23 %) |
| Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 9.19 | 14,574 | 133,935 | 132,282 | 146.9 K to 132.3 K (-9.92 %) |
| Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 27,566 | 0 | 146,856 | 119.3 K to 146.9 K (+23.11 %) |
| Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 67,633 | 0 | 67,633 | |
| Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 11.10 | 104,833 | 1,163,646 | 104,833 | |
| Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 4.56 | 30,000 | 136,800 | 0 | |
| Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 10.02 | 30,000 | 300,558 | 119,290 | 149.3 K to 119.3 K (-20.10 %) |
| Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 4.56 | 30,000 | 136,800 | 149,290 | 119.3 K to 149.3 K (+25.15 %) |
| Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.16 | 11,250 | 24,300 | 33,750 | |
| Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.40 | 8,750 | 21,000 | 0 | |
| Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 10.69 | 20,000 | 213,706 | 119,290 | 139.3 K to 119.3 K (-14.36 %) |
| Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.16 | 11,250 | 24,300 | 139,290 | 128 K to 139.3 K (+8.79 %) |
| Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.40 | 8,750 | 21,000 | 128,040 | 119.3 K to 128 K (+7.34 %) |
| Jul 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.40 | 35,000 | 84,000 | 0 | |
| Jul 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 24.95 | 35,000 | 873,208 | 119,290 | 154.3 K to 119.3 K (-22.68 %) |
| Jul 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.40 | 35,000 | 84,000 | 154,290 | 119.3 K to 154.3 K (+29.34 %) |
| Jul 02 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 26.50 | 35,000 | 927,500 | 119,290 | 154.3 K to 119.3 K (-22.68 %) |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 20,433 | 0 | 0 | |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 5.70 | 7,066 | 40,276 | 154,290 | 161.4 K to 154.3 K (-4.38 %) |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 20,433 | 0 | 161,356 | 140.9 K to 161.4 K (+14.50 %) |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 20,433 | 0 | 0 | |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 5.70 | 7,066 | 40,276 | 154,290 | 161.4 K to 154.3 K (-4.38 %) |
| Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 20,433 | 0 | 161,356 | 140.9 K to 161.4 K (+14.50 %) |
| Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 21,467 | 0 | 42,933 | |
| Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 27,567 | 0 | 27,566 | |
| Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 14.09 | 7,424 | 104,604 | 140,923 | 148.3 K to 140.9 K (-5.00 %) |
| Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 21,467 | 0 | 148,347 | 126.9 K to 148.3 K (+16.92 %) |
| Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 9.80 | 9,817 | 96,207 | 126,880 | 136.7 K to 126.9 K (-7.18 %) |
| Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 27,567 | 0 | 136,697 | 109.1 K to 136.7 K (+25.26 %) |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 64,400 | 0 | 64,400 | |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 3.34 | 100,500 | 335,670 | 100,500 | |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 20,433 | 0 | 20,433 | |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 3.34 | 7,066 | 23,600 | 109,130 | 116.2 K to 109.1 K (-6.08 %) |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 20,433 | 0 | 116,196 | 95.8 K to 116.2 K (+21.34 %) |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 3.34 | 8,591 | 28,694 | 95,763 | 104.4 K to 95.8 K (-8.23 %) |
| Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 25,000 | 0 | 104,354 | 79.4 K to 104.4 K (+31.50 %) |
| Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 27,567 | 0 | 55,133 | |
| Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 3.61 | 10,301 | 37,187 | 79,354 | 89.7 K to 79.4 K (-11.49 %) |
| Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 27,567 | 0 | 89,655 | 62.1 K to 89.7 K (+44.40 %) |
| Nov 30 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.00 | 10,001 | 20,002 | 0 | |
| Nov 30 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 5.28 | 10,001 | 52,805 | 62,088 | 72.1 K to 62.1 K (-13.87 %) |
| Nov 30 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.00 | 10,001 | 20,002 | 72,089 | 62.1 K to 72.1 K (+16.11 %) |
| Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 4.24 | 15,000 | 63,600 | 0 | |
| Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 4.45 | 10,000 | 44,500 | 62,088 | 72.1 K to 62.1 K (-13.87 %) |
| Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 4.43 | 25,000 | 110,750 | 72,088 | 97.1 K to 72.1 K (-25.75 %) |
| Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 4.24 | 15,000 | 63,600 | 97,088 | 82.1 K to 97.1 K (+18.27 %) |
| Mar 13 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 20,434 | 0 | 40,866 | |
| Mar 13 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Mar 13 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 4.51 | 6,899 | 31,114 | 82,088 | 89 K to 82.1 K (-7.75 %) |
| Mar 13 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 20,434 | 0 | 88,987 | 68.6 K to 89 K (+29.81 %) |
| Mar 13 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 4.51 | 8,421 | 37,979 | 68,553 | 77 K to 68.6 K (-10.94 %) |
| Mar 13 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 25,000 | 0 | 76,974 | 52 K to 77 K (+48.10 %) |
| Mar 07 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 82,700 | 0 | 82,700 | |
| Mar 07 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 4.29 | 126,500 | 542,685 | 126,500 | |
| Mar 07 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 8,333 | 0 | 0 | |
| Mar 07 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 4.29 | 3,407 | 14,616 | 51,974 | 55.4 K to 52 K (-6.15 %) |
| Mar 07 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 8,333 | 0 | 55,381 | 47 K to 55.4 K (+17.71 %) |
| Mar 13 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 61,300 | 0 | 61,300 | |
| Mar 13 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 6.68 | 100,000 | 668,000 | 100,000 | |
| Mar 13 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 25,000 | 0 | 50,000 | |
| Mar 13 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 6.61 | 9,171 | 60,620 | 47,048 | 56.2 K to 47 K (-16.31 %) |
| Mar 13 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 25,000 | 0 | 56,219 | 31.2 K to 56.2 K (+80.08 %) |
| Mar 07 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 8,333 | 0 | 8,333 | |
| Mar 07 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 6.95 | 3,640 | 25,298 | 31,219 | 34.9 K to 31.2 K (-10.44 %) |
| Mar 07 2017 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 8,333 | 0 | 34,859 | 26.5 K to 34.9 K (+31.41 %) |
| Mar 11 2016 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
| Mar 11 2016 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 7.02 | 67,500 | 473,850 | 67,500 | |
| Mar 08 2016 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 8,334 | 0 | 16,666 | |
| Mar 08 2016 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 7.48 | 3,196 | 23,906 | 26,526 | 29.7 K to 26.5 K (-10.75 %) |
| Mar 08 2016 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 8,334 | 0 | 29,722 | 21.4 K to 29.7 K (+38.97 %) |
| Mar 09 2015 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 7.56 | 60,000 | 453,600 | 60,000 | |
| Mar 09 2015 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | P | 8.80 | 514 | 4,523 | 514 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | P | 5,882.35 | 1 | 5,882 | 1 | 0 to 1 |
Page: 1